ARENSIA Dinner

WHAT TO EXPECT

Timely information, interactive format

After 2 years of virtual meetings, we are excited to meet face-to-face for an interactive roundtable discussion. In an informal setting, industry thought leaders will have an opportunity to exchange their vision of paradigm shifts in early clinical development following unprecedented challenges caused by the COVID-19 pandemic. The focus will be on practical aspects of the new normal in planning and execution of early phase clinical trials with real-life case studies.

Attendees will be able to address these issues and among other exciting
topics, we will discuss:

Use of creative design and new technologies in exploratory patient trials
Strategies for fast patient enrollment and retention
Operational tips for flawless study conduct
Takeaways after operating under COVID-19 pandemic

We will have the following COVID measures in place for your reassurance:

Rapid test station will be open at the registration desk
Health status and temperature check will be done at the registration desk
Face masks are optional; the venue will have permanent fresh-air flow. Mask requirements will be adjusted depending on recommendations at the time of the event.

Agenda

Dr. Claudia Hesselmann, PhD, Co-founder & CEO, Germany, ARENSIA

Dr. Claudia Hesselmann, PhD, Co-founder & CEO, Germany, ARENSIA and Tatiana Eidus, Director Corporate Development North America, USA, ARENSIA

Meet the Facilitators

The Dinner will be lead by our expert facilitators

Claudia Hesselmann, PhD

Co-founder & CEO ARENSIA

Tatiana Eidus

Director Corporate Development North America, USA Arensia

More about ARENSIA

More information

ARENSIA EXPLORATORY MEDICINE is a German operator of proprietary research clinics in Eastern Europe, dedicated to performing complex Phase Ib, IIa and PROOF-OF-CONCEPT clinical trials with novel molecules, involving patients across numerous disease areas. Given the outstanding patient recruitment rates achieved by ARENSIA clinics, we are able to substantially reduce the overall number of sites, countries and recruitment periods for any early phase patient trial.

Further Information

3 N Square, Boston, MA 02113, United States

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

Clinical Trials ARENSIA Boston

ARENSIA Dinner – 16th May

ARENSIA Boston Dinner

Timely information, interactive format

Agenda

Registration, Networking & Cocktails

Welcome and Introduction: New normal in exploratory clinical trials. Challenges and Future Trends

Roundtable Discussion: Accelerated performance of complex exploratory patient studies: Practical insights from investigational site

Dinner

Roundtable Discussion (Continued)

Closing Remarks, Coffee and Cognacs

Meet the Facilitators

Claudia Hesselmann, PhD

Tatiana Eidus

More about ARENSIA

Further Information

Select days you wish to attend You can add multiple days

Daily Delegate Rate includes:

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Orthopaedics

Cardiovascular

Infectious diseases

Pulmonology

CNS

Inflammation

Psychiatry

Dermatology

Internal diseases

Respiratory

Diabetes

Metabolic diseases

Rheumatology

Endocrinology

Nephrology

Surgery

ENT

Neurology

Urology

Gastroenterology

Oncology

Vaccines

Haematology

Ophthalmology

Thrombosis

Rare Diseases

This is required field*

0-10

10-50

50-100

100-500

500+

This is required field*

Under £100,000

£100,000 - £500,000

£500,000 - £1,000,000

£1,000,000 - £5,000,000

£5,000,000 - £10,000,000

£10,000,000 +

This is required field*

Discovery to Development

Pre-Clinical

Phase 1

Phase 2

Phase 3